The antioxidant enzyme PRDX4 reduces the efficacy of chemotherapy drugs like docetaxel and doxorubicin by mitigating the oxidative stress these drugs induce to kill cancer cells. This interaction affects the drugs' pharmacodynamics, altering their therapeutic effectiveness without changing their metabolism or elimination.